Bisolvon

ownerOpella (controlled by Clayton, Dubilier & Rice) (USA)

originGermany

Bisolvon is owned by Opella (controlled by Clayton, Dubilier & Rice), headquartered in the United States. Yes. The ultimate owner of Bisolvon, Opella (controlled by Clayton, Dubilier & Rice), is headquartered in the United States.

Opella is a global leader in consumer healthcare, managing iconic over-the-counter brands. In 2025, it became an independent champion following a stake sale to the investment firm Clayton, Dubilier & Rice (CD&R).

Opella Healthcare

Products from Bisolvon (5)

Bisolvon 2-IN-1 cough syrup for adults · Health care – Cough syrup
Bisolvon Cough Syrup · Personal care – Pharmaceutical (Mucolytic)
Bisolvon Drank cough syrup · Personal care – Medicine
Bisolvon bromhexinhydrochloride · Pharmaceutical – Mucolytic Agent
Bisolvon 8 mg tablets · Personal care – Pharmaceutical (Mucolytic)

Alternatives to Bisolvon

Teva · Teva Pharmaceutical Industries Ltd. (Israel)
Nurofen · Reckitt Benckiser Group plc (United Kingdom)
Gaviscon · Reckitt Benckiser Group plc (United Kingdom)
Cinfa · Infarco, S.A. (Spain)
Sandoz · Sandoz Group AG (Switzerland)
Dafalgan · Taisho Pharmaceutical Holdings Co., Ltd. (Japan)

Check another product

disclaimer

poweredBy